research

The Download: AI’s extinction risk and bioweapons threat

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Could AI really kill us all? Your questions, answered On Wednesday, MIT Technology Review hosted a live Roundtables event that asked the question many seem to be asking right now: could…

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Could AI really kill us all? Your questions, answered On Wednesday, MIT Technology Review hosted a live Roundtables event that asked the question many seem to be asking right now: could AI really kill us all? But attendees had more questions than we had time to answer, so we asked senior AI editor Will Douglas Heaven and AI reporter Grace Huckins to tackle some of the best ones. The questions they tried to answer include: am I going to die? Why should AI kill us, if at all? Is AI really dangerous, or is it just tech companies drumming up PR? And what steps can be taken to make sure AI is controlled, monitored and regulated effectively? Here are their responses. —Will Douglas Heaven and Grace Huckins The specter of AI-enabled bioweapons is a wake-up call for biotech One of the ways AI could potentially cause catastrophic harm is by aiding the design and creation of bioweapons. In 2022, researchers found that it was remarkably easy to do this with an AI “molecule generator” built to develop drugs. In less than six hours, the model generated 40,000 molecules that could serve as chemical warfare agents. Today, AI tools can answer questions on almost every area of science, while advances in gene editing and synthetic biology have made biotech tools more accessible. There are safeguards, but none are ironclad. However, scientists disagree about how serious the risk is anyway. Find out why it’s easier than ever to design killer pathogens. —Jessica Hamzelou This story is from The Checkup, our weekly biotech newsletter. Sign up to receive it in your inbox every Thursday. The role of the astronaut is in flux We go to space for geopolitical prestige, manifest destiny, spiritual fulfillment, scientific curiosity, and, increasingly, business opportunities. In the wake of Artemis II, a slew of new books suggest that these justifications are sub